AU3551193A - N-substituted chitosan derivatives, process for their preparation and the use thereof - Google Patents

N-substituted chitosan derivatives, process for their preparation and the use thereof

Info

Publication number
AU3551193A
AU3551193A AU35511/93A AU3551193A AU3551193A AU 3551193 A AU3551193 A AU 3551193A AU 35511/93 A AU35511/93 A AU 35511/93A AU 3551193 A AU3551193 A AU 3551193A AU 3551193 A AU3551193 A AU 3551193A
Authority
AU
Australia
Prior art keywords
structural elements
alkyl
co2h
alkoxy
mol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU35511/93A
Other versions
AU658986B2 (en
Inventor
Dieter Lohmann
Donald Richard Randell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU3551193A publication Critical patent/AU3551193A/en
Application granted granted Critical
Publication of AU658986B2 publication Critical patent/AU658986B2/en
Assigned to CIBA SPECIALTY CHEMICALS HOLDING INC. reassignment CIBA SPECIALTY CHEMICALS HOLDING INC. Alteration of Name(s) in Register under S187 Assignors: CIBA-GEIGY AG
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18—Manufacture of films or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Manufacturing & Machinery (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)

Abstract

Chitosan derivatives having structural elements of the formulae I, II and III in random distribution <IMAGE> in which the R1 are, independently of one another, H or the radical -Z-R2-X, R3 is H or acetyl, Y is the anion O-Z-R2-X, and (a) Z is -CO- or -SO2-, X is -CO2H, -CH2CO2H or -CH2PO(OH)2, and R 2 is -CHR4CR5(OH)-, R4 is -H, -OH, C1-C4-alkoxy or C1-C4-alkyl, and R5 is H or C1-C4-alkyl, or (b) Z is -CO-, X is -CO2H, and R2 is -CHR6-CHR7-CH(OH)- or -CHR8-CHR9-CHR10-CH(OH)-, R6, R7, R8 and R10 are, independently of one another, -H, -OH, C1-C4-alkyl or C1-C4-alkoxy and R9 is -H, -OH, C1-C4-alkyl, C1-C4-alkoxy or -CO2H, and their esters and salts, where the chitosan derivative contains a total of at least 2 structural elements and, based on one mole of the chitosan derivative, 30 to 100 mol% of structural elements of the formula I, 60 to 0 mol% of structural elements of the formula II and 30 to 0 mol% of structural elements of the formula III are present, and the mole percentages total 100%. They are suitable as wetting agents and for preventing adhesion and/or formation of solid deposits on inorganic or organic substrates.
AU35511/93A 1992-03-27 1993-03-26 N-substituted chitosan derivatives, process for their preparation and the use thereof Ceased AU658986B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH981/92 1992-03-27
CH98192 1992-03-27

Publications (2)

Publication Number Publication Date
AU3551193A true AU3551193A (en) 1993-09-30
AU658986B2 AU658986B2 (en) 1995-05-04

Family

ID=4199699

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35511/93A Ceased AU658986B2 (en) 1992-03-27 1993-03-26 N-substituted chitosan derivatives, process for their preparation and the use thereof

Country Status (9)

Country Link
EP (1) EP0563013B1 (en)
JP (1) JPH0641202A (en)
KR (1) KR100257092B1 (en)
AT (1) ATE152132T1 (en)
AU (1) AU658986B2 (en)
BR (1) BR9301334A (en)
CA (1) CA2092513A1 (en)
DE (1) DE59306229D1 (en)
MX (1) MX9301732A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863518A (en) * 1994-10-21 1999-01-26 Nihon Medi-Physics Co., Ltd. Diagnostic imaging agent with backbone with modified sugar chain end

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59409748D1 (en) * 1993-06-11 2001-06-21 Ciba Sc Holding Ag Bleaching aids
ES2151950T3 (en) * 1994-12-22 2001-01-16 Ciba Sc Holding Ag N-CYANOMETILATED CHITOSANS AND THEIR HYDROLYZED PRODUCTS.
KR100348804B1 (en) * 1998-12-07 2002-11-18 주식회사 태평양 A chitosanglucono delta lactone salt and a method for preparing of oligochitosan using the same
GB0221941D0 (en) 2002-09-20 2002-10-30 Univ Strathclyde Polysoaps
EP1440683A1 (en) * 2003-01-23 2004-07-28 Cognis France S.A. Use of oligoglucosamines in cosmetic or dermatologic compositions
US7390579B2 (en) 2003-11-25 2008-06-24 Magnequench, Inc. Coating formulation and application of organic passivation layer onto iron-based rare earth powders
JP5522615B2 (en) * 2006-09-15 2014-06-18 国立大学法人 宮崎大学 Polymers useful as precious metal ion scavengers
EP1955710A1 (en) * 2007-02-09 2008-08-13 The Jordanian Pharmaceutical Manufacturing Co. Aqueous composition comprising chitosan and an acidic drug
WO2008135957A2 (en) * 2007-05-07 2008-11-13 Koninklijke Philips Electronics N.V. A method for cleaning dental plaque from teeth using an adherent peelable gel
WO2023149402A1 (en) * 2022-02-03 2023-08-10 東ソー株式会社 Water-soluble chelating polymer and method for producing same
CN116813985B (en) * 2023-07-14 2024-02-09 唐山学院 Early warning material for hydrogen sulfide gas and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU419529A1 (en) * 1971-03-26 1974-03-15
US3953608A (en) * 1971-05-10 1976-04-27 L'oreal Cosmetic compositions for the skin containing a chitosan derivative
US3879376A (en) * 1971-05-10 1975-04-22 Oreal Chitosan derivative, method of making the same and cosmetic composition containing the same
DE3432227A1 (en) * 1984-09-01 1986-03-13 Wella Ag, 6100 Darmstadt Sulphopropyl derivatives of chitin and chitosan, process for their preparation, and their use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863518A (en) * 1994-10-21 1999-01-26 Nihon Medi-Physics Co., Ltd. Diagnostic imaging agent with backbone with modified sugar chain end

Also Published As

Publication number Publication date
AU658986B2 (en) 1995-05-04
EP0563013B1 (en) 1997-04-23
JPH0641202A (en) 1994-02-15
MX9301732A (en) 1994-01-31
BR9301334A (en) 1993-10-05
EP0563013A2 (en) 1993-09-29
CA2092513A1 (en) 1993-09-28
EP0563013A3 (en) 1994-04-20
KR100257092B1 (en) 2000-08-01
ATE152132T1 (en) 1997-05-15
KR930019700A (en) 1993-10-18
DE59306229D1 (en) 1997-05-28

Similar Documents

Publication Publication Date Title
AU3551193A (en) N-substituted chitosan derivatives, process for their preparation and the use thereof
CA2044497A1 (en) Surface treating agent for aluminum line pattern substrate
CA2053253A1 (en) New aryl-and heteroarylethenylene derivatives and process for their preparation
IE811566L (en) Steel articles protected against corrosion.
HU9401943D0 (en) Process for producing amide and urea derivatives and compositions containing them
MY131501A (en) Process for the prepration of clavulanic acid
CA2166203A1 (en) Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]- 6-chloro-1,3-dihydro-indol-2-one
CA2094335A1 (en) 4,1-benzoxazepin derivatives and their use
EP0725074A3 (en) Compounds suitable for use as intermediates in the preparation of Androst-3,5-dien-3-carboxy derivatives
CA2287907A1 (en) Novel orally active iron (iii) chelators
CA2141969A1 (en) Cardio-Protective Agent
CA2226406A1 (en) Novel pyridone carboxylic acid derivatives
AU4987690A (en) Hydroxyalkane carboxylic acid derivatives, their production and use
ATE166205T1 (en) TB-ACTIVE CARBOXYLIC ACID
ES2102327A1 (en) 2,2,6,6-tetramethylpiperidine derivatives for use as stabilizing agents for organic materials
ES2000907A6 (en) 2-Oxa-isocephem compounds, compositions containing same and processes for preparing same.
EP0630899A4 (en) Cephem compound, process for producing the same, and medicine containing the same.
CS302790A3 (en) Functional derivatives of 4-(2,4-difluorobiphenylyl)-2-methyl -4- oxobutanoic acid
CA2163080A1 (en) Cephem compound, process for producing the compound, and antimicrobial composition containing the same
IL110273A0 (en) Use of cephem derivatives as anti-metastatic agents
GR3006137T3 (en)
CA2208032A1 (en) Substituted amidinonaphthyl ester derivative
CA2139112A1 (en) Novel nicotinic acid esters
AU4441593A (en) Tetrahydronaphthalene derivatives, their preparation and their application in therapy
CA2279293A1 (en) Hexahydroindenopyridine compounds having antispermatogenic activity

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired